Table 1 Characteristics of sample
Age at presentation | Number of patients (Total = 35) |
|---|---|
ANC | 4 |
0–6 months | 9 |
6–12 months | 3 |
1–2 years | 11 |
2–5 years | 2 |
> 5 years | 6 |
Serum creatinine at presentation (mg%) | Number of patients |
|---|---|
0–1 | 10 |
01-Feb | 19 |
02-May | 3 |
> 5 | 3 |
Ultrasonography features at presentation | Number of patients |
|---|---|
Thick trabeculated bladder | 15 (42.8%) |
Dilated posterior urethra | 03 (8.5%) |
Normal kidneys | 04 (11.4%) |
Hydroureteronephrosis | 20 (57.1%) |
Renal cystic changes | 02 (5.7%) |
Pyonephrosis | 02 (5.7%) |
Shrunken kidneys | 01 (2.8%) |
CMD loss | 10 (28.5%) |
Raised Echoes | 11 (31.4%) |
Age at PUV fulguration | Number of patients |
|---|---|
0–1 month | 5 |
1–12 months | 6 |
1–2 years | 10 |
2–5 years | 5 |
> 5 years | 9 |
Interval between diagnosis of PUV and Valve fulguration | Number of patients |
|---|---|
0–1 month | 20 |
1–12 months | 10 |
1–2 years | 2 |
2–5 years | 2 |
> 5 years | 1 |